Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Jessie W. Gu"'
Background: Advances in biotechnology have raised expectations that biomarkers, including genetic profiles, will yield information to accurately predict outcomes for individuals. However, results to date have been disappointing. In addition, statisti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2d28c1df0b0312994bba1a0b211f12a
https://doi.org/10.1158/1055-9965.c.6515091
https://doi.org/10.1158/1055-9965.c.6515091
Supplementary Appendix from The Potential of Genes and Other Markers to Inform about Risk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c3fda3dd4bca4836366dfbda4f8feba
https://doi.org/10.1158/1055-9965.22435764
https://doi.org/10.1158/1055-9965.22435764
Autor:
Jessie W. Gu, Kristofer Munson, Ziding Feng, Katarzyna Lamparska-Kupsik, Jeffrey S. Yoshida, Mark H. Kawachi, Timothy G. Wilson, Kevin Chan, Steven S. Smith, Laura E. Crocitto, Jarrod Clark
Background: TMPRSS2:ERG fusions are promising prostate cancer biomarkers. Because they can occur in multiple forms in a single cancer specimen, we developed a quantitative PCR test that detects both type III and type VI TMPRSS2:ERG fusions. The assay
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7be07a1e79e3d6f8520c8adfa332c068
https://europepmc.org/articles/PMC2977928/
https://europepmc.org/articles/PMC2977928/